Articles

Open Access

Ferreira S, Faverani LP, Mendonça R, Souza FA, Garcia-Júnior IR. Bone reconstruction and optic functional restoration after fronto-orbital fibrous dysplasia resection. Head Neck Oncol 2014 Oct 18;6(6):54.

Open Access

Garcia NG, Rodrigues MTV, Soares CT, Oliveira DT. Immunoprofile of primary gingival angiosarcoma: A case report and review of the literature. Head Neck Oncol 2014 Sep 05;6(6):53.

Open Access

Pai P, Dutta A. Management of oral carcinoma in a patient with severe trimus using a novel approach. Head Neck Oncol 2014 Sep 05;6(6):52.

Open Access

Rocha JF, Carvalho THL, Almeida-Neto LF, Hochuli-Vieira E, Gonçales ES. Bilateral dentigerous cyst in non-syndromic patient: Case report and review of literature. Head Neck Oncol 2014 Sep 05;6(6):51.

Open Access

Agarwal SK, Gogia S, Agarwal A, Agarwal R, Mathur AS. Assessment of voice related quality of life and its correlation with socioeconomic status after total laryngectomy. Head Neck Oncol 2014 Sep 05;6(5):50.

Open Access

Goswami PN, Pandya SJ. Human papilloma virus in head and neck carcinoma: Experience from a regional cancer center in Gujarat. Head Neck Oncol 2014 Sep 05;6(5):48.

Open Access

Clarissa ASG, Eduardo Antônio GR, Emanuel SSA, José ZCF. Adenomatoid odontogenic tumour: hamartoma or neoplasm? A contribution to debate. Head Neck Oncol 2014 Sep 05;6(5):47.

Open Access

Zhuang SM, Zhang GH, Chen SW, Li H, Zhang J, Song M. Prognostic factors and survival in patients with squamous cell carcinoma lymph nodes metastases from an unknown primary to the head and neck. Head Neck Oncol 2014 Sep 05;6(5):46.

Open Access

Swastika N, Gwande M, Chaudhary M, Patil S, Bohra S, Hande A. Expression of hypoxia inducible factor-1 alpha (HIF-1α) in oral squamous cell carcinoma and its correlation with neoangiogenesis and 3-year survival from the disease. Head Neck Oncol 2014 Sep 05;6(5):45.

Open Access

Ozdemir S, Coban Y, Bakir A, Uzel O. Volumetric variations and the effects of these differences on dosimetry during the course of volumetric modulated arc therapy for head and neck cancer. Head Neck Oncol 2014 Sep 05;6(5):44.